During the last session, Immunocore Holdings plc ADR (NASDAQ:IMCR)’s traded shares were 0.82 million, with the beta value of the company hitting 0.81. At the end of the trading day, the stock’s price was $36.60, reflecting an intraday gain of 4.45% or $1.56. The 52-week high for the IMCR share is $49.05, that puts it down -34.02 from that peak though still a striking 36.75% gain since the share price plummeted to a 52-week low of $23.15. The company’s market capitalization is $1.84B, and the average trade volume was 376.03K shares over the past three months.
Immunocore Holdings plc ADR (IMCR) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.67. IMCR has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it.
Immunocore Holdings plc ADR (NASDAQ:IMCR) trade information
Immunocore Holdings plc ADR (IMCR) registered a 4.45% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.45% in intraday trading to $36.60, hitting a weekly high. The stock’s 5-day price performance is 17.27%, and it has moved by 21.59% in 30 days. Based on these gigs, the overall price performance for the year is -20.95%.
The consensus price target of analysts on Wall Street is $35, which implies a decrease of -4.57% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $35 and $35 respectively. As a result, IMCR is trading at a premium of 4.37% off the target high and 4.37% off the low.
While earnings are projected to return 23.65% in 2025, the next five years will return -9.63% per annum.
IMCR Dividends
Immunocore Holdings plc ADR is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 4.87 million shares, is of RTW INVESTMENTS, LP’s that is approximately 9.7369% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $165.04 million.
Also, the Mutual Funds coming in first place with the largest holdings of Immunocore Holdings plc ADR (IMCR) shares are VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund . Data provided on Jan 31, 2025 indicates that VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund owns about 4.58 shares. This amounts to just over 9.12 percent of the company’s overall shares, with a $167.72 million market value. The same data shows that the other fund manager holds slightly less at 1.76, or about 3.50% of the stock, which is worth about $64.28 million.
